PDF(Pubmed)
Abstract：
UNASSIGNED: The increasing population of survivors of head and neck carcinomas is becoming more conspicuous. Consequently, the pivotal role of quality of life, particularly elucidated through the assessment of dysphagia and dysphonia, is progressively influencing the decision-making process. The current study aims to assess whether VITOM 3D could offer a comparable post-treatment quality of life to traditional approaches for patients with laryngeal cancer and oro-hypopharyngeal cancer.
UNASSIGNED: A case series of laryngeal cancer and oro-hypopharyngeal cancer patients treated either with an exoscopic-assisted surgical setup and with conventional treatments (transoral microsurgery and radio-chemotherapy) at the Otolaryngology Unit of IRCCS San Martino Hospital, Genoa, is presented. The post-treatment quality of life of the two cohorts were compared through the administration of the University of Washington Quality of Life Questionnaire, Voiceik Handicap Index-10, M.D. Anderson Dysphagia Inventory were administrated to both cohorts of patients.
UNASSIGNED: In the laryngeal cancer group, a total of 79 patients were included. Of these, 50.1% underwent transoral exoscope-assisted surgery, while 49.9% underwent primary transoral microscopic-assisted surgical approach. No significant differences were observed in terms of the University of Washington Quality of Life Questionnaire and Voice Handicap Index-10 between the two subgroups. Conversely, in the oro-hypopharyngeal cancer group, 43 patients were included. Of these, 37.2% underwent primary transoral exoscope-assisted surgery, while 62.8% received (chemo)radiotherapy. No notable differences were reported in terms of the University of Washington Quality of Life Questionnaire and M.D. Anderson Dysphagia Inventory between the transoral exoscope-assisted surgery and (chemo)radiotherapy subgroups.
UNASSIGNED: Assessments of quality of life, conducted through the University of Washington Quality of Life Questionnaire questionnaire, dysphonia evaluations using the Voice Handicap Index-10, and dysphagia assessments employing the M.D. Anderson Dysphagia Inventory questionnaire, demonstrate analogous outcomes between conventional treatment modalities and transoral interventions utilizing the 3D exoscope.
UNASSIGNED: A case series of laryngeal cancer and oro-hypopharyngeal cancer patients treated either with an exoscopic-assisted surgical setup and with conventional treatments (transoral microsurgery and radio-chemotherapy) at the Otolaryngology Unit of IRCCS San Martino Hospital, Genoa, is presented. The post-treatment quality of life of the two cohorts were compared through the administration of the University of Washington Quality of Life Questionnaire, Voiceik Handicap Index-10, M.D. Anderson Dysphagia Inventory were administrated to both cohorts of patients.
UNASSIGNED: In the laryngeal cancer group, a total of 79 patients were included. Of these, 50.1% underwent transoral exoscope-assisted surgery, while 49.9% underwent primary transoral microscopic-assisted surgical approach. No significant differences were observed in terms of the University of Washington Quality of Life Questionnaire and Voice Handicap Index-10 between the two subgroups. Conversely, in the oro-hypopharyngeal cancer group, 43 patients were included. Of these, 37.2% underwent primary transoral exoscope-assisted surgery, while 62.8% received (chemo)radiotherapy. No notable differences were reported in terms of the University of Washington Quality of Life Questionnaire and M.D. Anderson Dysphagia Inventory between the transoral exoscope-assisted surgery and (chemo)radiotherapy subgroups.
UNASSIGNED: Assessments of quality of life, conducted through the University of Washington Quality of Life Questionnaire questionnaire, dysphonia evaluations using the Voice Handicap Index-10, and dysphagia assessments employing the M.D. Anderson Dysphagia Inventory questionnaire, demonstrate analogous outcomes between conventional treatment modalities and transoral interventions utilizing the 3D exoscope.
摘要：
■头颈部癌幸存者的增加越来越明显。因此,生活质量的关键作用，特别是通过评估吞咽困难和发音困难来阐明，正在逐步影响决策过程。目前的研究旨在评估VITOM3D是否可以为喉癌和口咽癌患者提供与传统方法相当的治疗后生活质量。
■在IRCCS圣马蒂诺医院的耳鼻喉科接受了一系列喉癌和口咽癌患者的手术治疗和常规治疗（经口显微外科手术和放化疗），热那亚,是presented。通过华盛顿大学生活质量问卷的管理，比较了两个队列的治疗后生活质量。VoiceikHandicapIndex-10，M.D.Anderson吞咽困难清单对两组患者进行了管理。
■在喉癌组中，共纳入79例患者.其中,50.1%接受了经口镜辅助手术，而49.9％的人接受了经口显微镜辅助的原发性手术入路。华盛顿大学生活质量问卷和语音障碍指数-10在两个亚组之间没有观察到显着差异。相反，在口咽癌组中，包括43例患者。其中,37.2%的人接受了原发性经口镜辅助手术，而62.8％接受（化学）放疗。华盛顿大学生活质量问卷和M.D.Anderson吞咽困难量表在经口外镜辅助手术和（化学）放疗亚组之间没有显着差异。
■生活质量评估，通过华盛顿大学生活质量问卷进行问卷调查，使用语音障碍指数10进行发音障碍评估，并使用MD安德森吞咽困难量表进行吞咽困难评估，证明了传统治疗方式和利用3D外镜的经口干预之间的类似结果。
■在IRCCS圣马蒂诺医院的耳鼻喉科接受了一系列喉癌和口咽癌患者的手术治疗和常规治疗（经口显微外科手术和放化疗），热那亚,是presented。通过华盛顿大学生活质量问卷的管理，比较了两个队列的治疗后生活质量。VoiceikHandicapIndex-10，M.D.Anderson吞咽困难清单对两组患者进行了管理。
■在喉癌组中，共纳入79例患者.其中,50.1%接受了经口镜辅助手术，而49.9％的人接受了经口显微镜辅助的原发性手术入路。华盛顿大学生活质量问卷和语音障碍指数-10在两个亚组之间没有观察到显着差异。相反，在口咽癌组中，包括43例患者。其中,37.2%的人接受了原发性经口镜辅助手术，而62.8％接受（化学）放疗。华盛顿大学生活质量问卷和M.D.Anderson吞咽困难量表在经口外镜辅助手术和（化学）放疗亚组之间没有显着差异。
■生活质量评估，通过华盛顿大学生活质量问卷进行问卷调查，使用语音障碍指数10进行发音障碍评估，并使用MD安德森吞咽困难量表进行吞咽困难评估，证明了传统治疗方式和利用3D外镜的经口干预之间的类似结果。
